France launches major study to track rare blood disorder patients
NCT ID NCT02877706
Summary
This study is creating a national registry to track 1500 adult patients in France who have immune thrombocytopenia (ITP) or autoimmune hemolytic anemia (AIHA). The goal is to understand how these rare blood disorders progress in real life and see how well current treatments work outside of controlled trials. Researchers will collect information on symptoms, treatments used, side effects, and whether doctors follow recommended care guidelines.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Service de Médecine Interne
RECRUITINGToulouse, 31000, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.